What is the level of liabilities of Zomedica this year?
Zomedica has a debt balance of 13.18 M USD this year.
Zomedica Liabilities 2024
Zomedica Liabilities
13.18 M USD
Ticker
ZOM
ISIN
CA98980M1095
WKN
A2QEF3
In 2024, Zomedica's total liabilities amounted to 13.18 M USD, a 7.87% difference from the 12.22 M USD total liabilities in the previous year.
Zomedica Aktienanalyse
What does Zomedica do?
Zomedica Corp is an emerging company specializing in the development and marketing of innovative diagnostics and treatment options for pets. The company was founded in 2015 and is headquartered in Ann Arbor, Michigan. Zomedica's business model is primarily focused on providing better diagnostics and therapy for pets to veterinarians and pet owners. The company develops and markets veterinary diagnostics and precise treatment solutions for various diseases in pets. Zomedica is divided into different divisions specializing in different areas of veterinary diagnostics and therapy. One of these divisions is "Point-of-Care" diagnostics, which allows veterinarians to perform quick and accurate diagnoses directly in their practice. Zomedica offers innovative devices and tests for the rapid diagnosis of diseases such as prostatitis or hypothyroidism. Another important division is "Companion Diagnostic" diagnostics, which is specifically focused on the diagnosis of cancer in pets. Zomedica has developed innovative tests that enable quick and precise diagnoses, allowing for targeted therapy initiation. In addition to diagnostics, Zomedica also offers innovative therapy solutions for pets. The company focuses on the development of antibiotics for animals, as well as precise treatment solutions for diseases such as diabetes or chronic kidney disease. One of Zomedica's best-known products is TRUFORMA, an innovative diagnostic device for veterinarians that enables quick and precise diagnosis of various diseases. The company has also developed a range of tests for the diagnosis of thyroid disease, prostatitis, and diabetes. In recent years, Zomedica has become one of the leading companies in veterinary diagnostics and therapy and has already convinced numerous veterinarians and pet owners of its innovative products and solutions. The company relies on close collaboration with veterinarians to continuously improve its products and tailor them to the needs of the market. Overall, Zomedica is an innovative company specializing in products and solutions for the needs of veterinarians and pet owners. With its innovative diagnostics and treatment solutions, the company is setting new standards in veterinary medicine and contributing to the improvement of pet health worldwide. Zomedica ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Zomedica's Liabilities
Zomedica's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Zomedica's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Zomedica's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Zomedica's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Zomedica’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Zomedica stock
What were the liabilities of Zomedica compared to the previous year?
The liabilities of Zomedica have increased by 7.87% increased compared to the previous year.
What are the consequences of high debt for investors of Zomedica?
High liabilities can pose a risk for investors of Zomedica, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Zomedica?
Low liabilities mean that Zomedica has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Zomedica affect the company?
An increase in liabilities of Zomedica can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Zomedica affect the company?
A decrease in the liabilities of Zomedica can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Zomedica?
Some factors that can influence the liabilities of Zomedica include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Zomedica so important for investors?
The liabilities of Zomedica are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Zomedica take to modify the liabilities?
To change its liabilities, Zomedica can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Zomedica pay?
Over the past 12 months, Zomedica paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zomedica is expected to pay a dividend of 0 USD.
What is the dividend yield of Zomedica?
The current dividend yield of Zomedica is .
When does Zomedica pay dividends?
Zomedica pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Zomedica?
Zomedica paid dividends every year for the past 0 years.
What is the dividend of Zomedica?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Zomedica located?
Zomedica is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zomedica kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zomedica from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.
When did Zomedica pay the last dividend?
The last dividend was paid out on 11/9/2024.
What was the dividend of Zomedica in the year 2023?
In the year 2023, Zomedica distributed 0 USD as dividends.
In which currency does Zomedica pay out the dividend?
The dividends of Zomedica are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zomedica
Our stock analysis for Zomedica Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zomedica Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
